{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001228","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.326896+00:00","generated_at":"2026-06-12T11:47:04.510518+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Herbalife Q2 net sales $1.3B (-5.7% YoY); EPS $0.60; board member becomes CSO; targets Q4 growth","bullets":["Q2 net sales $1.3B, down 5.7% YoY (4.2% constant currency); net income $59.9M.","Diluted EPS $0.60; adjusted diluted EPS $0.74; adjusted EBITDA $169.6M.","Transformation Program: at least $90M annual cost savings expected; $45M anticipated in 2023.","Stephan Gratziani resigned from Board to become Chief Strategy Officer effective August 1, 2023.","Management states on track to return to growth in fourth quarter 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001228","json":"https://secwatch.observer/filing/0001157523-23-001228.json","markdown":"https://secwatch.observer/filing/0001157523-23-001228.md","text":"https://secwatch.observer/filing/0001157523-23-001228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000115752323001228/0001157523-23-001228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000115752323001228/a53503456.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T11:47:04.510518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91b45b593d42e6f0295f11ca2bef1b74ccf4d08c","claim":"HERBALIFE LTD. reported second quarter ended June 30, 2023 results: revenue $1.3 billion, net income $59.9 million, EPS $0.60.","evidence_excerpt":"Second quarter 2023 net sales of $1.3 billion, down 5.7% compared to second quarter 2022; on a constant currency basis 1 , net sales declined 4.2% compared to the prior year period Year-over-year reported net sales trends improved for two sequential quarters Second quarter 2023 reported net income of $59.9 million and adjusted EBITDA 2 of $169.6 million Second quarter 2023 reported diluted EPS of $0.60 and adjusted diluted EPS 2 of $0.74","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000115752323001228/0001157523-23-001228-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$1.3 billion"},{"label":"Net income","value":"$59.9 million"},{"label":"EPS","value":"$0.60"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"7050c6be50","claim":"Stephan Gratziani resigned as Director at HERBALIFE LTD..","evidence_excerpt":"On August 1, 2023, Mr. Stephan Gratziani resigned from the Company’s Board of Directors (the “Board”) and agreed to become an employee of the Company in the role of Chief Strategy Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000115752323001228/0001157523-23-001228-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9a53608ff0","claim":"Stephan Gratziani was appointed as Chief Strategy Officer at HERBALIFE LTD..","evidence_excerpt":"On August 1, 2023, Mr. Stephan Gratziani resigned from the Company’s Board of Directors (the “Board”) and agreed to become an employee of the Company in the role of Chief Strategy Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000115752323001228/0001157523-23-001228-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"agreed to become"},{"label":"Role","value":"Chief Strategy Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}